Pseudomonas aeruginosa Pneumonia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Published	Pages	Publisher	Report code
May 2022	34	Global Markets Direct	ASDR-601496

Published: May 2022 - Pages : 34 - Publisher : Global Markets Direct - Report code : ASDR-601496

Aridis Pharmaceuticals Inc
Armata Pharmaceuticals Inc
AstraZeneca Plc
Ayuvis Research Inc
Pedanius Therapeutics Ltd